Antiretroviral Therapy Current Events | Antiretroviral Therapy News | 3
|
| Page
3 of
36 |
712 Results |
|
|
|
Sort By:
Page Views | Date |
Six months after start of treatment could be optimum time for making prognosis in patients with HIV/AIDS (p 679)
Issue 30 August 2003 Embargoed 0001 h (London time) 29 August 2003. An international study in this week's issue of THE LANCET suggests that prognosis for patients with HIV/AIDS might be more reliably determined six months after initiation of highly active antiretroviral therapy (HAART), rather than before the start of treatment. HAART became... view more... (2003-08-27)
Genetic Testing Could Identify HIV Patients At Risk Of Hypersensitivty To HIV Drug (pp 722, 727)
HIV patients at risk of a potentially fatal hypersensitive reaction to the antiretroviral drug abacavir could be identified by genetic testing before drug therapy has started, suggest authors of a fast-track study in this week's issue of THE LANCET. The use of the HIV antiretroviral drug abacavir, a potent HIV-1 nucleoside-analogue... view more... (2002-02-28)
Study shows common vitamin and other micronutrient supplements reduce risks of TB recurrence
New findings show a link between micronutrient supplementation and reduced risk of recurrence during tuberculosis chemotherapy, according to a study published in the June 1 issue of The Journal of Infectious Diseases, now available online. view more (2008-04-28)
HIV Mortality in India Drops with Introduction of Generic Antiretroviral Therapy
The survival rate of HIV-infected patients in India has risen in response to a 20-fold drop in the price of antiretroviral therapy (ART), according to an article in the Nov. 15 issue of Clinical Infectious Diseases, now available online. view more (2005-10-20)
Early administration of antiretroviral therapy can improve survival
The first antiretroviral treatments appeared in 1996. Since then, new and better drugs have been discovered that have almost turned AIDS into a chronic disease. view more (2009-04-10)
OHSU researchers discover possible HIV therapy in an animal study
Researchers have published a new study this week suggesting an important component of the immune system damaged by AIDS can possibly be replaced. view more (2006-06-09)
Study shows suppressing herpes virus may reduce infectiousness of HIV
A recent study of men co-infected with herpes simplex virus type 2 (HSV-2) and HIV revealed that drugs used to suppress HSV decrease the levels of HIV in the blood and rectal secretions, which may make patients less likely to transmit the virus. view more (2007-11-16)
First results of the Narval trial (ANRS 088)
Patients with HIV infection may develop resistance to one or more of antiretroviral drugs to which they are exposed during treatment. The selection of the most appropriate drugs for switching therapy in patients who have developed resistance, is a difficult challenge. Both, genetic tests that identify mutations in viral genes associated with... view more... (2000-04-21)
Efficiency and feasibility of antiretroviral therapy in Africa demonstrated in IRD-coordinated surveys
Three-quarters of all people hit by HIV live in Sub-Saharan Africa. It is vital therefore that antiretroviral treatments, available and effective in industrialized countries, can be used for patients in Africa. Several enquiries, coordinated by the Institut de Recherche pour le Développement (IRD) are bringing proof that such treatments are... view more... (2002-07-10)
Breastfeeding now safer for infants of HIV-infected mothers
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding. view more (2008-02-05)
HIV measurement appears to be less reliable than thought in predicting loss of CD4 cells
Preliminary research indicates that the initial HIV RNA level in untreated HIV-infected patients appears to have little value in predicting the rate of CD4 cell count decrease. view more (2006-09-27)
Gene therapy shows promise as weapon against HIV
A new UCLA AIDS Institute study has found that gene therapy can be developed as a safe and active technique to combat HIV. view more (2009-02-23)
Study highlights HIV/AIDS challenge in American prison system
HIV/Aids is up to five times more prevalent in American prisons than in the general population. Adherence to treatment programs can be strictly monitored in prison. view more (2009-09-30)
Integrating antiretroviral therapy with TB treatment for co-infections reduces mortality
A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time. view more (2008-10-17)
World aides series : advances in research in prevention of mother-to-child HIV-1 transmission
'Although substantial progress has been made in preventing mother-to-child HIV-1 transmission in the past decade, critical research questions remain. Two perinatal epidemics now exist. In more-developed countries, integration of prenatal HIV-1 counselling and testing programmes into an existing antenatal infrastructure, availability of effective... view more... (2000-06-22)
UC Davis study finds HIV hiding from drugs in gut, preventing immune recovery
UC Davis researchers have discovered that the human immunodeficiency virus, the virus that causes AIDS, is able to survive efforts to destroy it by hiding out in the mucosal tissues of the intestine. view more (2006-07-31)
HIV integrase inhibitor effective for patients beginning antiretroviral treatment
A member of a new class of antiretroviral drugs is safe and effective for patients beginning treatment against HIV, according to researchers who have completed a two-year multisite phase III clinical trial comparing it with standard antiretroviral drugs. view more (2009-08-03)
Focusing HIV treatment helps control concurrent hepatitis B infection
Prolonged use of highly active antiretroviral therapy (HAART) to treat people infected with both HIV and hepatitis B (HBV) helps to better control the hepatitis B infection and could delay or prevent liver complications. view more (2009-07-15)
Using hair to manage HIV/AIDS and predict treatment success
UCSF researchers have found that examining levels of antiretroviral drugs in hair samples taken from HIV patients on therapy strongly predicts treatment success. view more (2009-03-04)
South African Government Urged To Take Action In Preventing Mother-To-Child HIV Transmission (p 992)
Leading South African scientists, writing in a Commentary in this week's issue of THE LANCET, are calling on their government to implement antiretroviral drug programmes without delay to reduce the vertical transmission of HIV-1 infection from pregnant women to their children. Around 75,000 South African children were born with HIV-1 infection in... view more... (2002-03-20)
|
|
| Page
3 of
36 |
712 Results |
|
|
|
Sort By:
Page Views | Date |
|
